{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:02:56Z","timestamp":1750132976838,"version":"3.41.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,16]]},"DOI":"10.7759\/cureus.86124","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:30:43Z","timestamp":1750077043000},"source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of S-Adenosyl-L-Methionine for Intrahepatic Cholestasis in the United Arab Emirates"],"prefix":"10.7759","author":[{"given":"Ahmad","family":"Jazzar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiser","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar N","family":"Fasseeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Rasmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad N","family":"Fasseeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Cholestatic jaundice","author":"Grant LM","year":"2025","unstructured":"Grant LM, John S. Cholestatic jaundice. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i2.46","article-title":"Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: a systematic review","volume":"12","author":"Noureddin M","year":"2020","unstructured":"Noureddin M, Sander-Struckmeier S, Mato JM. Early treatment efficacy of S-adenosylmethionine in patients with intrahepatic cholestasis: a systematic review. World J Hepatol. 2020, 12:46-63. 10.4254\/wjh.v12.i2.46","journal-title":"World J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030","volume":"24","author":"Alswat K","year":"2018","unstructured":"Alswat K, Aljumah AA, Sanai FM, et al.. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030. Saudi J Gastroenterol. 2018, 24:211-9. 10.4103\/sjg.SJG_122_18","journal-title":"Saudi J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.23736\/S1121-421X.18.02461-3","article-title":"Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease","volume":"64","author":"Ivashkin VT","year":"2018","unstructured":"Ivashkin VT, Maevskaya MV, Kobalava ZD, et al.. Open-label study of ademetionine for the treatment of intrahepatic cholestasis associated with alcoholic liver disease. Minerva Gastroenterol Dietol. 2018, 64:208-19. 10.23736\/S1121-421X.18.02461-3","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref5","article-title":"Ademetionine in treatment of drug induced liver injury: an observational study in Russian patients, receiving immunosuppressive therapy for psoriasis","volume":"5","author":"Perlamutrov Y","year":"2014","unstructured":"Perlamutrov Y, Bakulev A, Korsunskaya I, Orlov E, Bolotnikova N. Ademetionine in treatment of drug induced liver injury: an observational study in Russian patients, receiving immunosuppressive therapy for psoriasis. Int J Pharmac Sc Res. 2014, 5:1000-7.","journal-title":"Int J Pharmac Sc Res"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1007\/BF03258369","article-title":"Multicentre double-blind placebo-controlled study of intravenous and oral s-adenosyl-L-methionine (SAMe) in cholestatic patients with liver disease","volume":"4","author":"Manzillo G","year":"1992","unstructured":"Manzillo G, Piccinino F, Surrenti C, Frezza M, Giudici G, Le Grazie C. Multicentre double-blind placebo-controlled study of intravenous and oral s-adenosyl-L-methionine (SAMe) in cholestatic patients with liver disease. Drug Investigation. 1992, 4:90-100.","journal-title":"Drug Investigation"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote EJ","year":"1994","unstructured":"Heathcote EJ, Cauch-Dudek K, Walker V, et al.. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 1994, 19:1149-56.","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.018","article-title":"Health-related quality of life in patients with nonalcoholic fatty liver disease: a prospective multi-center UK study","volume":"21","author":"Papatheodoridi M","year":"2023","unstructured":"Papatheodoridi M, Pallini G, Aithal G, et al.. Health-related quality of life in patients with nonalcoholic fatty liver disease: a prospective multi-center UK study. Clin Gastroenterol Hepatol. 2023, 21:3107-3114.e3. 10.1016\/j.cgh.2023.04.018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1581","article-title":"Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: the impact on patient-reported outcomes","volume":"4","author":"Younossi ZM","year":"2020","unstructured":"Younossi ZM, Wong VW, Anstee QM, et al.. Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: the impact on patient-reported outcomes. Hepatol Commun. 2020, 4:1637-50. 10.1002\/hep4.1581","journal-title":"Hepatol Commun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12462","article-title":"Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis","volume":"5","author":"McPhail SM","year":"2021","unstructured":"McPhail SM, Amarasena S, Stuart KA, et al.. Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis. JGH Open. 2021, 5:133-42. 10.1002\/jgh3.12462","journal-title":"JGH Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0964-1","article-title":"Factors influencing on health-related quality of life in South Korean with chronic liver disease","volume":"16","author":"Kim HJ","year":"2018","unstructured":"Kim HJ, Chu H, Lee S. Factors influencing on health-related quality of life in South Korean with chronic liver disease. Health Qual Life Outcomes. 2018, 16:142. 10.1186\/s12955-018-0964-1","journal-title":"Health Qual Life Outcomes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.06.019","article-title":"Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy","volume":"129","author":"Kondrackiene J","year":"2005","unstructured":"Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology. 2005, 129:894-901. 10.1053\/j.gastro.2005.06.019","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-090344","article-title":"Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions","volume":"14","author":"Aldallal S","year":"2024","unstructured":"Aldallal S, Farghaly M, Fahmy S, et al.. Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions. BMJ Open. 2024, 14:090344. 10.1136\/bmjopen-2024-090344","journal-title":"BMJ Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4716061\/v1","article-title":"Cost-effectiveness analysis of S-ademetionine compared with ursodeoxycholic acid for the treatment of Intrahepatic Cholestasis in China (Preprint)","author":"Kim H","year":"2024","unstructured":"Kim H, Lyu J, Royle R, Kim K, Morales-Castillo M, Byrnes J. Cost-effectiveness analysis of S-ademetionine compared with ursodeoxycholic acid for the treatment of Intrahepatic Cholestasis in China (Preprint). Research Square. 2024, 10.21203\/rs.3.rs-4716061\/v1","journal-title":"Research Square"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337893-cost-effectiveness-of-s-adenosyl-l-methionine-for-intrahepatic-cholestasis-in-the-united-arab-emirates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:30:44Z","timestamp":1750077044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337893-cost-effectiveness-of-s-adenosyl-l-methionine-for-intrahepatic-cholestasis-in-the-united-arab-emirates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.86124","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,16]]}}}